Polymorphisms of mouse apolipoprotein A-II alter its physical and functional nature

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sontag, Timothy J ^a   Reardon, Catherine A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; AMINO ACID; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID;

ALPHA HELIX; ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; C57BL 6 MOUSE; CHOLESTEROL TRANSPORT; CIRCULAR DICHROISM; CONTROLLED STUDY; FEMALE; FVB/N MOUSE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION;

ANIMALS; APOLIPOPROTEIN A-II; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL; CIRCULAR DICHROISM; DIMYRISTOYLPHOSPHATIDYLCHOLINE; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; UNILAMELLAR LIPOSOMES;

EID: 84895738718     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088705     Document Type: Article

References (40)

1. Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86: 19L-22L.
2. Eisenberg S (1984) High density lipoprotein metabolism. J Lipid Res 25: 1017-1058.
3. Pászty C, Maeda N, Verstuyft J, Rubin EM (1994) Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 94: 899-903.
4. Duverger N, Kruth H, Emmanuel F, Caillaud JM, Viglietta C, et al. (1996) Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94: 713-717. (Pubitemid 26289227)
5. Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, et al. (1998) ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J Lipid Res 39: 313-321. (Pubitemid 28100669)
6. Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, et al. (2003) Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler Thromb Vasc Biol 23: 1914-1920. (Pubitemid 37254884)
7. Moore RE, Navab M, Millar JS, Zimetti F, Hama S, et al. (2005) Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ Res 97: 763-771. (Pubitemid 41447126)
8. Winkler K, Hoffmann MM, Seelhorst U, Wellnitz B, Boehm BO, et al. (2008) Apolipoprotein A-II Is a negative risk indicator for cardiovascular and total mortality: findings from the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem 54: 1405-1406.
9. Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, et al. (2007) Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation 116: 2029-2035. (Pubitemid 350023748)
10. Deeb SS, Takata K, Peng RL, Kajiyama G, Albers JJ (1990) A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet 46: 822-827.
11. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ (1993) Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 261: 469-472. (Pubitemid 23276555)
12. Weng W, Breslow JL (1996) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci U S A 93: 14788-14794.
13. Miller CG, Lee TD, LeBoeuf RC, Shively JE (1987) Primary structure of apolipoprotein A-II from inbred mouse strain BALB/c. J Lipid Res 28: 311-319. (Pubitemid 17042849)
14. Kitagawa K, Wang J, Mastushita T, Kogishi K, Hosokawa M, et al. (2003) Polymorphisms of mouse apolipoprotein A-II: seven alleles found among 41 inbred strains of mice. Amyloid 10: 207-214. (Pubitemid 38117504)
15. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, et al. (1999) Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19: 1960-1968. (Pubitemid 29379929)
16. Teupser D, Persky AD, Breslow JL (2003) Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 23: 1907-1913. (Pubitemid 37254883)
17. Sontag TJ, Carnemolla R, Vaisar T, Reardon CA, Getz GS (2012) Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J Lipid Res 53: 951-963.
18. Wang X, Korstanje R, Higgins D, Paigen B (2004) Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res 14: 1767-1772. (Pubitemid 39276435)
19. Doolittle MH, LeBoeuf RC, Warden CH, Bee LM, Lusis AJ (1990) A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. J Biol Chem 265: 16380-16388.
20. Wang Y, Sawashita J, Qian J, Zhang B, Fu X, et al. (2011) ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis. J Lipid Res 52: 1461-1470.
21. Smith LE, Yang J, Goodman L, Huang X, Huang R, et al. (2012) High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli. J Lipid Res 53: 1708-1715.
22. Johnson WC (1999) Analyzing protein circular dichroism spectra for accurate secondary structures. Proteins 35: 307-312.
23. Lund-Katz S, Nguyen D, Dhanasekaran P, Kono M, Nickel M, et al. (2010) Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles. J Lipid Res 51: 606-617.
24. Wool GD, Reardon CA, Getz GS (2008) Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res 49: 1268-1283.
25. Oram JF, Vaughan AM, Stocker R (2001) ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem 276: 39898-39902.
26. Sankaranarayanan S, Oram JF, Asztalos BF, Vaughan AM, Lund-Katz S, et al. (2009) Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J Lipid Res 50: 275-284.
27. Rogers DP, Roberts LM, Lebowitz J, Datta G, Anantharamaiah GM, et al. (1998) The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry 37: 11714-11725. (Pubitemid 28400043)
28. Smith LE, Davidson WS (2010) The role of hydrophobic and negatively charged surface patches of lipid-free apolipoprotein A-I in lipid binding and ABCA1-mediated cholesterol efflux. Biochim Biophys Acta 1801: 64-69.
29. Chou CY, Jen WP, Hsieh YH, Shiao MS, Chang GG (2006) Structural and functional variations in human apolipoprotein E3 and E4. J Biol Chem 281: 13333-13344.
30. Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD (2012) High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 32: 2813-2820.
31. Cabana VG, Feng N, Reardon CA, Lukens J, Webb NR, et al. (2004) Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res 45: 317-325. (Pubitemid 38228830)
32. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, et al. (1989) Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res 30: 1397-1403. (Pubitemid 19253291)
33. Osada J, Fernández-Sánchez A, Diaz-Morillo JL, Miró-Obradors MJ, Cebrián JA, et al. (1994) Differential effect of dietary fat saturation and cholesterol on hepatic apolipoprotein gene expression in rats. Atherosclerosis 108: 83-90. (Pubitemid 24216371)
34. Lopez J, Latta M, Collet X, Vanloo B, Jung G, et al. (1994) Purification and characterization of recombinant human apolipoprotein A-II expressed in Escherichia coli. Eur J Biochem 225: 1141-1150. (Pubitemid 24342561)
35. Natarajan P, Forte TM, Chu B, Phillips MC, Oram JF, et al. (2004) Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1. J Biol Chem 279: 24044-24052. (Pubitemid 38725263)
36. Tanaka M, Koyama M, Dhanasekaran P, Nguyen D, Nickel M, et al. (2008) Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I. Biochemistry 47: 2172-2180. (Pubitemid 351287143)
37. Vedhachalam C, Narayanaswami V, Neto N, Forte TM, Phillips MC, et al. (2007) The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry 46: 2583-2593. (Pubitemid 46417902)
38. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, et al. (2006) ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26: 534-540.
39. Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, et al. (1994) Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest 94: 2457-2467.
40. Hedrick CC, Castellani LW, Wong H, Lusis AJ (2001) In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. J Lipid Res 42: 563-570. (Pubitemid 32366999)